MedTrace Logo

Probiotic Supplementation on Weight Loss

NCT03832439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2022-02-21

No results posted yet for this study

Summary

The investigators are trying to better understand how bariatric surgery leads to weight loss, and the role of bacteria that live in the gut in making this happen.

Conditions

  • Bariatric Surgery Candidate

Interventions

DIETARY_SUPPLEMENT

Probiotic

Lactobacillus rhamnosus GG 10 billion cells and microcrystalline cellulose

DIETARY_SUPPLEMENT

microcrystalline cellulose

Placebo

Sponsors & Collaborators

Principal Investigators

  • Meera Shah, M.B., Ch.B · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-17
Primary Completion
2021-04-28
Completion
2021-04-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03832439 on ClinicalTrials.gov